New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 26, 2013
20:30 EDTSCMPSucampo receives $10M milestone payment from Takeda
Sucampo Pharmaceuticals announced that it has received a $10M milestone payment from Takeda, pursuant to the existing collaboration and license agreement between SPI and Takeda. The milestone payment was triggered by the commercial launch of AMITIZA in the United States for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain. This is the third indication for AMITIZA.
News For SCMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 21, 2014
18:02 EDTSCMPSucampo, Takeda enter into global licensing agreement for AMITIZA
Subscribe for More Information
October 14, 2014
06:47 EDTSCMPSucampo signs amendment to license agreement for AMITIZA with Takeda
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use